Torbjörn Lundström was born in 1953. He is a physician with cardiology and internal medicine as clinical specialties, and a doctor of medical sciences. He has extensive clinical experience from healthcare, but also 20 years of experience in clinical drug development from senior positions within AstraZeneca, where he has been responsible for clinical development of products in mainly advanced development phase in cardiovascular and metabolic diseases. Torbjörn Lundström most recently came from a position as Global Clinical Lead, AstraZeneca R&D. He took over as Chief Medical Officer in 2020. Shareholding: 0 shares
Back